Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

May 27, 2022

Study Completion Date

May 27, 2022

Conditions
Polyneuropathy, AmyloidNeuropathic PainCardiac FailureOrthostatic HypotensionGastrointestinal Disorders
Trial Locations (11)

1000

University Hospital Skopje, Department of Neurology, Skopje

4600

Klinikum Wels-Grieskirchen GmbH, Abteilung für Neurologie, Wels

6725

University of Szeged, Department of Neurology, Szeged

7624

University of Pécs, Department of Neurology, Pécs

11000

Clinical Hospital Center Zvezdara, Department of Neurology, Belgrade

University of Belgrade, Clinical Center of Serbia, Neurology Clinic, Neuropathy Center, Belgrade

18000

Clinical Center Niš, Department of Neurology, Niš

20700

Hospital Universitario Donostia, San Sebastián

23000

"General Hospital Dr. Djordje Joanović", Zrenjanin

28031

Hospital Infanta Leonor, Madrid

31-503

Jagiellonian University Medical College, Department of Neurology, Krakow

All Listed Sponsors
lead

CENTOGENE GmbH Rostock

INDUSTRY

NCT01705626 - Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP) | Biotech Hunter | Biotech Hunter